1. Akhlaghi L, Gharavi M, Faghihi A, Jabbari M (2005) Survey on the prevalence rates of intestinal parasites in diabetic patients in Karaj and Savodjbolagh Cities. Razi J Med Sci 12(45):23–29
2. Daryani A et al (2014) Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop 137:185–194. doi: 10.1016/j.actatropica.2014.05.015
3. Gharavi MJ, Oormazdi H, Roointan ES (2008) A comparative study on sensitivity and specificity of conventional and unconventional IgG and IgM assays for diagnosis of toxoplasmosis. Iran J Public Health 37(4):42–45
4. Ghasemian M, Maraghi S, Saki J, Pedram M (2007) Determination of antibodies (IgG, IgM) against Toxoplasma gondii in patients with cancer. Iran J Parasitol 2(4):1–6
5. Gokce C, Yazar S, Bayram F, Gundogan K, Yaman O, Sahin I (2008) Anti-Toxoplasma gondii antibodies in type 2 diabetes. Natl Med J India 21(1):51